Reckitt Benckiser Group PLC (OTCMKTS:RBGLY - Get Free Report) has earned a consensus rating of "Moderate Buy" from the eight research firms that are covering the stock, MarketBeat.com reports. Four analysts have rated the stock with a hold recommendation, two have assigned a buy recommendation and two have issued a strong buy recommendation on the company.
RBGLY has been the topic of several recent research reports. Citigroup started coverage on Reckitt Benckiser Group in a report on Wednesday, January 14th. They issued a "buy" rating on the stock. Jefferies Financial Group reissued a "hold" rating on shares of Reckitt Benckiser Group in a report on Wednesday, January 7th. Barclays upgraded shares of Reckitt Benckiser Group from a "hold" rating to a "strong-buy" rating in a research report on Monday, December 1st. Royal Bank Of Canada lowered shares of Reckitt Benckiser Group from an "outperform" rating to a "sector perform" rating in a research note on Wednesday, January 14th. Finally, Morgan Stanley upgraded shares of Reckitt Benckiser Group from an "equal weight" rating to an "overweight" rating in a research report on Monday, March 16th.
Check Out Our Latest Analysis on Reckitt Benckiser Group
Reckitt Benckiser Group Stock Down 1.6%
OTCMKTS RBGLY opened at $13.59 on Friday. Reckitt Benckiser Group has a 52 week low of $12.49 and a 52 week high of $17.80. The company has a debt-to-equity ratio of 1.01, a current ratio of 0.56 and a quick ratio of 0.37. The stock has a fifty day moving average of $16.36 and a 200-day moving average of $15.92.
About Reckitt Benckiser Group
(
Get Free Report)
Reckitt Benckiser Group plc is a multinational consumer goods company that develops, manufactures and markets health, hygiene and home products. Its portfolio spans over-the-counter medicines and health products, personal and sexual wellness, surface and laundry cleaning, and household care. The company owns a number of well-known global brands across these categories, including Lysol and Dettol in disinfectants and hygiene, Durex in sexual wellness, Nurofen in analgesics, and Finish in dishwashing products.
The firm has its corporate headquarters in the United Kingdom and sells products in markets around the world, serving consumers across North America, Europe, Asia, Latin America, the Middle East and Africa.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of ten stocks that are set to soar in 2026, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.